From the Food and Drug Administration.
Nightingale
S L
SL
Office of Health Affairs, FDA, Rockville, MD 20857.
D001426:Bacterial Proteins; D001428:Bacterial Vaccines; D001815:Bloodletting / Q000295:instrumentation*; D016026:Bone Marrow Transplantation; D004866:Equipment Contamination; D006084:Graft Rejection; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use*; D018073:Haemophilus Vaccines; D006509:Hepatitis B / Q000635:transmission*; D006801:Humans; D007223:Infant; D014481:United States; D014486:United States Food and Drug Administration; D014614:Vaccines, Synthetic
D001426:Bacterial Proteins; D001428:Bacterial Vaccines; D018073:Haemophilus Vaccines; D014614:Vaccines, Synthetic; C061963:HibTITER protein, Haemophilus influenzae; D016178:Granulocyte-Macrophage Colony-Stimulating Factor